Vaxcyte, Inc.PCVXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P30
Within normal range
vs 5Y Ago
-3.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -41.14% |
| Q3 2025 | -52.83% |
| Q2 2025 | 47.34% |
| Q1 2025 | -36.48% |
| Q4 2024 | -43.16% |
| Q3 2024 | 40.76% |
| Q2 2024 | 2.59% |
| Q1 2024 | 7.90% |
| Q4 2023 | -186.47% |
| Q3 2023 | -7.07% |
| Q2 2023 | -13.70% |
| Q1 2023 | 19.69% |
| Q4 2022 | -68.49% |
| Q3 2022 | 1.68% |
| Q2 2022 | -30.83% |
| Q1 2022 | 41.64% |
| Q4 2021 | -74.14% |
| Q3 2021 | 2.44% |
| Q2 2021 | -113.74% |
| Q1 2021 | -25.77% |
| Q4 2020 | 12.18% |
| Q3 2020 | -41.80% |
| Q2 2020 | 34.01% |
| Q1 2020 | 8.97% |
| Q4 2019 | -61.37% |
| Q3 2019 | 30.42% |
| Q2 2019 | -39.81% |
| Q1 2019 | 0.00% |